Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Eli Lilly and Company

LLY
Current price
537.45 USD -7 USD (-1.29%)
Last closed 544.45 USD
Sector Healthcare
Industry Drug Manufacturers-General
Exchange NYSE
Capitalization 509 894 819 840 USD
Yield for 12 month +67.14 %
Week
Month
Year
LLY
21.11.2021 - 28.11.2021

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana. Address: Lilly Corporate Center, Indianapolis, IN, United States, 46285

Analytics

WallStreet Target Price

569.28 USD

P/E ratio

74.6014

Dividend Yield

0.84 %

Current Year

+28 541 400 000 USD

Last Year

+28 318 400 000 USD

Current Quarter

+8 312 100 000 USD

Last Quarter

+6 960 000 000 USD

Current Year

+21 911 600 000 USD

Last Year

+21 005 600 000 USD

Current Quarter

+6 504 700 000 USD

Last Quarter

+5 333 300 000 USD

Key Figures LLY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 9 765 000 192 USD
Operating Margin TTM 28.12 %
PE Ratio 74.6014
Return On Assets TTM 10.18 %
PEG Ratio 2.1814
Return On Equity TTM 65.6 %
Wall Street Target Price 569.28 USD
Revenue TTM 29 515 499 520 USD
Book Value 12.3 USD
Revenue Per Share TTM 32.76 USD
Dividend Share 4.22 USD
Quarterly Revenue Growth YOY 28.1 %
Dividend Yield 0.84 %
Gross Profit TTM 21 911 600 000 USD
Earnings Share 7.2 USD
Diluted Eps TTM 7.2 USD
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY 85.7 %
Profit Margin 22.01 %

Dividend Analytics LLY

Dividend growth over 5 years

88 %

Continuous growth

8 years

Payout Ratio 5 years average

56 %

Dividend History LLY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 4.52
Ex Dividend Date 14.08.2023
Forward Annual Dividend Yield 0.84 %
Last Split Factor 2:1
Payout Ratio 56.03 %
Last Split Date 16.10.1997
Dividend Date 08.09.2023

Stock Valuation LLY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 74.6014
Forward PE 39.0625
Enterprise Value Revenue 12.1805
Price Sales TTM 11.699
Enterprise Value EBITDA 42.0381
Price Book MRQ 34.0617

Financials LLY

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators LLY

For 52 weeks

307.74 USD 601.84 USD
50 Day MA 531.76 USD
Shares Short Prior Month 5 185 112
200 Day MA 420.49 USD
Short Ratio 2.27
Shares Short 6 267 421
Short Percent 0.79 %